KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the benefits of using AlloFlo to create a cyclodialysis cleft in patients with glaucoma.
According to Singh, AlloFlo (Iantrek), a bio-interventional enhancement for uveoscleral outflow, has shown good safety and efficacy to reinforce the cyclodialysis opening with sclera.
“The data look very promising so far, it’s already approved in the United States, and we’ve had a chance to use it in our center as well,” he said.